Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

LLM 2021 | ITP update: diagnosis, treatment & COVID-19 vaccines

James Bussel • 11 Oct 2021
LLM 2021
Immune Thrombocytopenia Non-Malignant

James Bussel, MD, Weill Cornell Medicine, New York, NY, gives an update on the diagnosis and treatment of immune thrombocytopenia (ITP). Diagnosis of immune thrombocytopenia (ITP) is often challenging as there is no specific testing, and there is a lack of categorization into subgroups leading to identical treatment strategies for all patients. Regarding ITP management, there have been new additions to the ITP armamentarium as well as relevant changes in established treatments. For instance, there has been a significant focus on reducing the dose and duration of steroids, which involves starting second-line agents earlier in the treatment course. Finally, Prof. Bussel discusses ITP related to COVID-19 vaccination, including de novo ITP and ITP exacerbation. This interview took place at the Lymphoma, Leukemia & Myeloma Congress 2021.

Related Videos

2:01
The MDT in the new era of gene therapy for hemoglobinopathies
Mattia Algeri • 15 Apr 2024
2:38
Treosulfan vs busulfan conditioning in pediatric patients with non-malignant diseases
Rita Beier • 15 Apr 2024
2:18
A global view of transfusion-dependent thalassemia: standard of care, outcomes, and unmet needs
Ali Taher • 15 Apr 2024
1:24
The future of CAR T-reg cells: organ transplantation & autoimmune disease
Zinaida Good • 9 Apr 2024
The content of VJHemOnc is intended for healthcare professionals